SK2652001A3 - 2-oxo-i(2h)-quinoline derivatives - Google Patents

2-oxo-i(2h)-quinoline derivatives Download PDF

Info

Publication number
SK2652001A3
SK2652001A3 SK265-2001A SK2652001A SK2652001A3 SK 2652001 A3 SK2652001 A3 SK 2652001A3 SK 2652001 A SK2652001 A SK 2652001A SK 2652001 A3 SK2652001 A3 SK 2652001A3
Authority
SK
Slovakia
Prior art keywords
methyl
oxo
quinoline
group
oxadiazol
Prior art date
Application number
SK265-2001A
Other languages
English (en)
Slovak (sk)
Inventor
Horst Juraszyk
Hanns Wurziger
Joachim Gante
Dieter Dorsch
Hans-Peter Buchstaller
Sabine Bernotat-Danielowski
Guido Melzer
Soheila Anzali
Werner Mederski
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of SK2652001A3 publication Critical patent/SK2652001A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/50—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
SK265-2001A 1998-08-29 1999-07-26 2-oxo-i(2h)-quinoline derivatives SK2652001A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19839499A DE19839499A1 (de) 1998-08-29 1998-08-29 2-Oxo-2H-chinolinderivate
PCT/EP1999/005315 WO2000012479A1 (de) 1998-08-29 1999-07-26 2-oxo-2h-chinolinderivate

Publications (1)

Publication Number Publication Date
SK2652001A3 true SK2652001A3 (en) 2001-09-11

Family

ID=7879227

Family Applications (1)

Application Number Title Priority Date Filing Date
SK265-2001A SK2652001A3 (en) 1998-08-29 1999-07-26 2-oxo-i(2h)-quinoline derivatives

Country Status (17)

Country Link
EP (1) EP1107954A1 (de)
JP (1) JP2002523494A (de)
KR (1) KR20010072862A (de)
CN (1) CN1315942A (de)
AR (1) AR021782A1 (de)
AU (1) AU5164199A (de)
BR (1) BR9913140A (de)
CA (1) CA2342230A1 (de)
DE (1) DE19839499A1 (de)
HK (1) HK1042478A1 (de)
HU (1) HUP0103212A3 (de)
ID (1) ID27863A (de)
NO (1) NO20010996L (de)
PL (1) PL346045A1 (de)
SK (1) SK2652001A3 (de)
WO (1) WO2000012479A1 (de)
ZA (1) ZA200102565B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100513398C (zh) 2002-12-03 2009-07-15 Axys药物公司 作为因子viia抑制剂的2-(2-羟基联苯-3-基)-1h-苯并咪唑-5-甲脒衍生物
MY187540A (en) 2014-08-01 2021-09-28 Nuevolution As Compounds active towards bromodomains

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI59246C (fi) * 1974-06-24 1981-07-10 Otsuka Pharma Co Ltd Foerfarande foer framstaellning av benscykloamidderivat anvaendbara vid trombos- och emboliterapin
IE43079B1 (en) * 1975-03-20 1980-12-17 Ici Ltd Quinolone derivatives
JPS596858B2 (ja) * 1975-04-30 1984-02-15 オオツカセイヤク カブシキガイシヤ ３，４−ジヒドロカルボスチリル誘導体の製造法
AT347956B (de) * 1976-03-18 1979-01-25 Ici Ltd Verfahren zur herstellung von neuen chinol-2- on-4-yl-alkansaeuren und von deren basenadditionssalzen
DE2651581A1 (de) * 1976-11-12 1978-05-18 Merck Patent Gmbh Chinolonderivate und verfahren zu ihrer herstellung
EP0550464A1 (de) * 1990-09-07 1993-07-14 Schering Corporation Anti-virale und anti-hypertensive verbindungen
CA2091172C (en) * 1990-09-07 1997-05-20 Adriano Afonso Antiviral compounds and antihypertensive compounds
ZA928276B (en) * 1991-10-31 1993-05-06 Daiichi Seiyaku Co Aromatic amidine derivates and salts thereof.
DE4208304A1 (de) * 1992-03-16 1993-09-23 Merck Patent Gmbh 2-oxochinolinderivate
IL115420A0 (en) * 1994-09-26 1995-12-31 Zeneca Ltd Aminoheterocyclic derivatives
US5612353A (en) * 1995-06-07 1997-03-18 Rhone-Poulenc Rorer Pharmaceuticals Inc. Substituted (sulfinic acid, sulfonic acid, sulfonylamino or sulfinylamino) N-[(aminoiminomethyl)phenylalkyl]-azaheterocyclylamide compounds
DE19528418A1 (de) * 1995-08-02 1997-02-06 Merck Patent Gmbh Endothelin-Rezeptor-Antagonisten
DE19530996A1 (de) * 1995-08-23 1997-02-27 Boehringer Mannheim Gmbh Cyclische Guanidine, Verfahren zu ihrer Herstellung und Arzneimittel
US5968959A (en) * 1997-12-12 1999-10-19 Orion Corporation Method for the prevention and treatment of stunned myocardium

Also Published As

Publication number Publication date
BR9913140A (pt) 2001-05-08
HK1042478A1 (zh) 2002-08-16
DE19839499A1 (de) 2000-03-02
ID27863A (id) 2001-04-26
NO20010996D0 (no) 2001-02-27
CN1315942A (zh) 2001-10-03
HUP0103212A2 (hu) 2002-05-29
AU5164199A (en) 2000-03-21
PL346045A1 (en) 2002-01-14
HUP0103212A3 (en) 2002-06-28
CA2342230A1 (en) 2000-03-09
NO20010996L (no) 2001-02-27
WO2000012479A1 (de) 2000-03-09
EP1107954A1 (de) 2001-06-20
AR021782A1 (es) 2002-08-07
KR20010072862A (ko) 2001-07-31
JP2002523494A (ja) 2002-07-30
ZA200102565B (en) 2002-06-28

Similar Documents

Publication Publication Date Title
USRE43481E1 (en) Diazepan derivatives or salts thereof
US6492384B1 (en) Imidazo (4,5-C) pyridine-4-one derivatives with factor XA inhibiting effect
AU2010286933A1 (en) Morpholinone compounds as factor IXa inhibitors
SK9442001A3 (en) Imidazo[4,5-c]-pyridine-4-on-derivatives, process for the preparation thereof, use thereof and pharmaceutical composition comprising same
SK492001A3 (en) Biphenyl derivatives
JP4732757B2 (ja) カルボキサミド
KR20010102428A (ko) 인자 ｘａ 억제제로서의 피라졸-３-온 유도체
SK2652001A3 (en) 2-oxo-i(2h)-quinoline derivatives
US6380430B1 (en) Biphenyl derivatives
JP4409941B2 (ja) 第Ｘａ因子阻害剤としてのフェニル誘導体
JP4699985B2 (ja) カルボキサミド誘導体及びその第Ｘａ因子の阻害剤としての使用
US7183277B2 (en) Carboxylic acid amides
CZ2001680A3 (cs) Derivát 2-oxo-2H-chinoIinu, způsob jeho přípravy, jeho použití a farmaceutický prostředek, který ho obsahuje
SK100096A3 (en) 1,3-benzodioxole-5-ylacetic acid derivative, preparing process thereof and pharmaceutical composition containing them
MXPA01006942A (en) Imidazo[4,5-c]-pyridine-4-on-derivatives
SK1972003A3 (en) Acetamide derivatives and the use thereof as inhibitors of coagulation factors XA and VIIA
KR20040095256A (ko) 세미카르바자이드 유도체 및 항혈전제로서의 이의 용도